Researchers from Institute of Urology at University College Hospital, London, have finally succeeded in proving that increasing testosterone levels did not give way to prostate cancer, instead it benefitted the patients of prostate cancer.

After carrying a research for 15-years on about 1,500 men, the researchers have managed to break the myth that increasing testosterone levels resulted in prostate cancer. The breakthrough has aroused the hopes of many men who suffered from the condition of male menopause or andropause. As per sources, around 2 million men in the UK suffer from the condition.

The revelation has also encouraged the access to treatments for andropause among men. Andropause or testosterone deficiency syndrome generally occurs among men who are aged 50 and above. The sufferers of the condition experience weight gain, anxiety, fatigue, brain fog, forgetfulness, sleep deprivation and incapable to have satisfactory sex. Many men in their 30s and 40s also experience the problem.

The treatment called Testosterone Replacement Treatment (TRT) for the syndrome is available in the NHS hospitals, but generally, doctors did not prescribe the treatment due to the fear of cancer contraction.

As per the Andropause Society's Chief Executive, Paul Pennington, "The experience of clinicians has shown that rather than being dangerous, carefully regulated and monitored TRT has been shown to be remarkably safe".